| Tbio | Nuclear pore complex protein Nup160 |
Involved in poly(A)+ RNA transport.
NUP160 is 1 of up to 60 proteins that make up the 120-MD nuclear pore complex, which mediates nucleoplasmic transport.[supplied by OMIM, Apr 2004]
NUP160 is 1 of up to 60 proteins that make up the 120-MD nuclear pore complex, which mediates nucleoplasmic transport.[supplied by OMIM, Apr 2004]
Comments
| Disease | Target Count | P-value |
|---|---|---|
| glioblastoma | 5792 | 1.4e-10 |
| osteosarcoma | 7950 | 3.6e-08 |
| atypical teratoid / rhabdoid tumor | 5112 | 1.2e-07 |
| primitive neuroectodermal tumor | 3035 | 6.5e-07 |
| Astrocytoma, Pilocytic | 3081 | 4.7e-06 |
| medulloblastoma, large-cell | 6241 | 3.7e-05 |
| psoriasis | 6694 | 1.5e-04 |
| adult high grade glioma | 3801 | 2.1e-04 |
| lung cancer | 4740 | 9.0e-04 |
| group 3 medulloblastoma | 4104 | 1.3e-03 |
| oligodendroglioma | 2850 | 3.7e-03 |
| ependymoma | 4679 | 6.1e-03 |
| ovarian cancer | 8520 | 6.3e-03 |
| intraductal papillary-mucinous neoplasm (IPMN) | 3291 | 2.3e-02 |
| aldosterone-producing adenoma | 665 | 3.1e-02 |
| astrocytic glioma | 2597 | 4.2e-02 |
| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| Vascular cancer | 3 | 3.001 | 1.5 |
| Disease | log2 FC | p |
|---|---|---|
| adult high grade glioma | 2.000 | 2.1e-04 |
| aldosterone-producing adenoma | -1.030 | 3.1e-02 |
| astrocytic glioma | 1.700 | 4.2e-02 |
| Astrocytoma, Pilocytic | 1.600 | 4.7e-06 |
| atypical teratoid / rhabdoid tumor | 2.300 | 1.2e-07 |
| ependymoma | 2.500 | 6.1e-03 |
| glioblastoma | 2.100 | 1.4e-10 |
| group 3 medulloblastoma | 2.100 | 1.3e-03 |
| intraductal papillary-mucinous neoplasm ... | 1.100 | 2.3e-02 |
| lung cancer | 1.300 | 9.0e-04 |
| medulloblastoma, large-cell | 2.500 | 3.7e-05 |
| oligodendroglioma | 2.300 | 3.7e-03 |
| osteosarcoma | -2.205 | 3.6e-08 |
| ovarian cancer | -1.200 | 6.3e-03 |
| primitive neuroectodermal tumor | 2.700 | 6.5e-07 |
| psoriasis | -1.700 | 1.5e-04 |
MLHLSAAPPAPPPEVTATARPCLCSVGRRGDGGKMAAAGALERSFVELSGAERERPRHFREFTVCSIGTA 1 - 70 NAVAGAVKYSESAGGFYYVESGKLFSVTRNRFIHWKTSGDTLELMEESLDINLLNNAIRLKFQNCSVLPG 71 - 140 GVYVSETQNRVIILMLTNQTVHRLLLPHPSRMYRSELVVDSQMQSIFTDIGKVDFTDPCNYQLIPAVPGI 141 - 210 SPNSTASTAWLSSDGEALFALPCASGGIFVLKLPPYDIPGMVSVVELKQSSVMQRLLTGWMPTAIRGDQS 211 - 280 PSDRPLSLAVHCVEHDAFIFALCQDHKLRMWSYKEQMCLMVADMLEYVPVKKDLRLTAGTGHKLRLAYSP 281 - 350 TMGLYLGIYMHAPKRGQFCIFQLVSTESNRYSLDHISSLFTSQETLIDFALTSTDIWALWHDAENQTVVK 351 - 420 YINFEHNVAGQWNPVFMQPLPEEEIVIRDDQDPREMYLQSLFTPGQFTNEALCKALQIFCRGTERNLDLS 421 - 490 WSELKKEVTLAVENELQGSVTEYEFSQEEFRNLQQEFWCKFYACCLQYQEALSHPLALHLNPHTNMVCLL 491 - 560 KKGYLSFLIPSSLVDHLYLLPYENLLTEDETTISDDVDIARDVICLIKCLRLIEESVTVDMSVIMEMSCY 561 - 630 NLQSPEKAAEQILEDMITIDVENVMEDICSKLQEIRNPIHAIGLLIREMDYETEVEMEKGFNPAQPLNIR 631 - 700 MNLTQLYGSNTAGYIVCRGVHKIASTRFLICRDLLILQQLLMRLGDAVIWGTGQLFQAQQDLLHRTAPLL 701 - 770 LSYYLIKWGSECLATDVPLDTLESNLQHLSVLELTDSGALMANRFVSSPQTIVELFFQEVARKHIISHLF 771 - 840 SQPKAPLSQTGLNWPEMITAITSYLLQLLWPSNPGCLFLECLMGNCQYVQLQDYIQLLHPWCQVNVGSCR 841 - 910 FMLGRCYLVTGEGQKALECFCQAASEVGKEEFLDRLIRSEDGEIVSTPRLQYYDKVLRLLDVIGLPELVI 911 - 980 QLATSAITEAGDDWKSQATLRTCIFKHHLDLGHNSQAYEALTQIPDSSRQLDCLRQLVVVLCERSQLQDL 981 - 1050 VEFPYVNLHNEVVGIIESRARAVDLMTHNYYELLYAFHIYRHNYRKAGTVMFEYGMRLGREVRTLRGLEK 1051 - 1120 QGNCYLAALNCLRLIRPEYAWIVQPVSGAVYDRPGASPKRNHDGECTAAPTNRQIEILELEDLEKECSLA 1121 - 1190 RIRLTLAQHDPSAVAVAGSSSAEEMVTLLVQAGLFDTAISLCQTFKLPLTPVFEGLAFKCIKLQFGGEAA 1191 - 1260 QAEAWAWLAANQLSSVITTKESSATDEAWRLLSTYLERYKVQNNLYHHCVINKLLSHGVPLPNWLINSYK 1261 - 1330 KVDAAELLRLYLNYDLLEEAVDLVSEYVDAVLGKGHQYFGIEFPLSATAPMVWLPYSSIDQLLQALGENS 1331 - 1400 ANSHNIALSQKILDKLEDYQQKVDKATRDLLYRRTL 1401 - 1436 //
